Psyence Biomedical Ltd. Files August 2025 Report (6-K)
Ticker: PBMWW · Form: 6-K · Filed: Aug 28, 2025 · CIK: 1985062
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer
TL;DR
Psyence Biomedical (PSYG) filed a 6-K on 8/28, includes press release. Check for updates.
AI Summary
Psyence Biomedical Ltd. filed a Form 6-K on August 28, 2025, reporting for the month of August 2025. The filing includes a press release as Exhibit 99.1. The company's principal executive office is located at 121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario, M5H 2K1. Dr. Neil Maresky signed the report on behalf of Psyence Biomedical Ltd.
Why It Matters
This filing provides an update on Psyence Biomedical Ltd.'s activities and regulatory compliance for the month of August 2025, including a press release that may contain material information for investors.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that primarily serves to submit a press release and confirm company information, not indicating any immediate operational or financial distress.
Key Players & Entities
- Psyence Biomedical Ltd. (company) — Registrant
- August 2025 (date) — Reporting period
- 121 Richmond Street West Penthouse Suite 1300 Toronto, Ontario M5H 2K1 (location) — Principal executive office address
- Dr. Neil Maresky (person) — Signatory for the report
- 001-41937 (other) — SEC file number
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report for the month of August 2025 and to submit a press release (Exhibit 99.1) as required for foreign private issuers.
Who signed this report on behalf of Psyence Biomedical Ltd.?
Dr. Neil Maresky signed this report on behalf of Psyence Biomedical Ltd.
What is the SEC file number for Psyence Biomedical Ltd.?
The SEC file number for Psyence Biomedical Ltd. is 001-41937.
Where is Psyence Biomedical Ltd.'s principal executive office located?
Psyence Biomedical Ltd.'s principal executive office is located at 121 Richmond Street West, Penthouse Suite 1300, Toronto, Ontario, M5H 2K1.
Does Psyence Biomedical Ltd. file annual reports under Form 20-F or 40-F?
Psyence Biomedical Ltd. indicated that it files annual reports under cover of Form 20-F.
Filing Stats: 158 words · 1 min read · ~1 pages · Grade level 10 · Accepted 2025-08-28 16:05:03
Filing Documents
- ea0255028-6k_psyence.htm (6-K) — 9KB
- ea025502801ex99-1_psyence.htm (EX-99.1) — 18KB
- 0001213900-25-081729.txt ( ) — 29KB
From the Filing
OF FOREIGN PRIVATE ISSUER UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2025 Commission File Number: 001-41937 Psyence Biomedical Ltd. (Translation of registrant’s name into English) 121 Richmond Street West Penthouse Suite 1300 Toronto, Ontario M5H 2K1 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F EXHIBIT INDEX Exhibit No. Description 99.1 Press Release 1 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Dated: August 28, 2025 Psyence Biomedical Ltd. By: /s/ Dr. Neil Maresky Name: Dr. Neil Maresky Title: Chief Executive Officer and Director 2